What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“I have been able to work on a project focused on studying novel cell lines generated from patient with rare undifferentiated sarcomas in children, but also have had the opportunity to shadow in the clinic on a couple of occasions. This experience has awoken the idea of possibly pursing a career as a physician scientist and/or many other options that I had not considered in the past as career choices.”

Bryan Kynnap, Health Sciences, ’16


Trainee Spotlight


Ryan Pan

Health Sciences, '20

Synthesis of DFO-Lys(PEG30k)-Cys(Cy3) to examine macropinocytosis in human and mouse cancers in vitro

Kaylie DeCosmo

Health Sciences, '20

Nanoparticle-aided radio-immunotherapy

Esteban Enrique

Biochemistry, '20

Assessing sufficiency of the Tip60/p400 complex in inducing transcription of Merkel Cell Polyomavirus Small T antigen target genes.

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Tracy Batchelor, M.D.

Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology,

Develops novel therapeutics for malignant primary brain tumors. Students will have the opportunity to image and characterize tumor markers of sensitivity and resistance to anti-angiogenic therapeutics, with the goal of defining and exploiting alternative pro-angiogenic targets.


Ross I Berbeco, Ph.D.

Associate Professor of Radiation Oncology, HMS

Our lab performs theoretical and experimental studies of systemically administered nanoparticles and their role in enhancing radiation therapy for cancer treatment. Students will have the opportunity to functionalize these particles with tumor-specific targeting moieties and study how this leads to localized disruption of the tumor vasculature.


Trainee Spotlight


Jessica Munck

Behavioral Neuroscience, '20

Assessment of atherosclerotic changes following neoadjuvant therapy using ferumoxytol as contrast imaging agent

Esteban Enrique

Biochemistry, '20

Assessing sufficiency of the Tip60/p400 complex in inducing transcription of Merkel Cell Polyomavirus Small T antigen target genes.

Ryan Pan

Health Sciences, '20

Synthesis of DFO-Lys(PEG30k)-Cys(Cy3) to examine macropinocytosis in human and mouse cancers in vitro


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...